- Maximising freedom to operate to protect and generate revenue from your patents
In the Chair:
Dr. Giampiero De Luca
Hear from your eminent Speaker Panel:
Peter De Weerd
Peter Buhl Jensen
Dr. Neil C. Thomas
The life sciences sector is one of the fastest growing industries in the global economy today. The cornerstone of a pharmaceutical or a biotechnology company is its intellectual property. According to an independent survey, the life sciences sector attracted 28 % of all venture capital investments in 2005 or $ 6 billion in 608 deals.
A well-managed Patent Portfolio is being used to protect your R & D, generate revenue, cross-licensing and to enter strategic alliances with partners. In a smaller biotechnology company, one patent can make it all to generate revenue. In a pharmaceutical company, the Patent Portfolio is used to ensure freedom to operate in the global patent landscape.
Through competitive analysis of third party patents, the patent attorneys are able to successfully design-around patent and avoid infringements with your competitors. By optimising the IP value it is possible to make licensing deals with preferred partners at the right time in order to maximise the revenue from your innovations.
This top tier programme is comprehensive and covers the most important key issues to build strong Patent Portfolios in pharmaceutical and biotechnology companies. At this international one-day conference, industry leaders will present detailed case studies to support your company to sustain an advantage in a highly competitive business environment.
This conference will tackle key issues such as:
Target audience and Job Titles:
Presidents, Chief Executive Officers, Chief IP Counsels, Vice Presidents, Directors and Heads of:
Official Hotel & Airline: